ArticleFrontiers in immunology2018

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases.

Timo Rath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.